Tag: #Global Trends

IQVIA and Kexing Biopharm have announced an expansion of their strategic collaboration to support a global, multi-product biosimilar development and... Read more

AstraZeneca has entered into a three-year licensing agreement to integrate K Pro, Owkin’s "AI Scientist," into its IT infrastructure and... Read more

The European Commission (EC) has granted marketing authorization to expand the approved indication for Hympavzi (marstacimab). The expansion now covers... Read more

Eli Lilly has released new data addressing a fundamental hurdle in obesity treatment: weight regain after discontinuing GLP-1 therapy. The... Read more

Takeda Pharmaceutical is launching a comprehensive "Transformation Program" for fiscal year 2026 as it prepares for a leadership transition and... Read more

BeOne Medicines has officially entered the BCL-2 landscape following the FDA’s accelerated approval of Beqalzi (sonrotoclax). This milestone marks the... Read more

Arvinas and its partner Pfizer have reached a long-awaited licensing agreement for Veppanu, the first-of-its-kind "PROTAC" breast cancer medicine. According... Read more

Bristol Myers Squibb (BMS) and Hengrui Pharma have launched a global strategic collaboration and licensing agreement. The partnership encompasses 13... Read more

Boehringer Ingelheim has entered into a global licensing agreement with Immunitas Therapeutics for a preclinical antibody program. This transaction underscores... Read more